Germany / Highest Honours for BioNTech Founders; Bayer’s Growth Predictions; Merck Making Further French Investments
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
CRELUX
Last updated: 13.02.2014
Address: Am Klopferspitz 19a, 82152 Martinsried,Germany
Tel: +49 (0) 89 700760 283
Company description
CRELUX provides fast and affordable access to co-crystal structures of compounds in complex with their protein targets. As an integrated protein service provider the company also delivers batches of ultra pure protein certified for use in crystallization or assays. Crystallization conditions of numerous relevant therapeutic targets have been established at CRELUX. Co-crystal structures of these targets in complex with compounds of interest to clients are delivered at a fixed price with a typical turn around time of only a few months.
Products and services
Related
Germany / STADA’s Bold Bets on M&A
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness…
Germany / The Biotech Behind Pfizer’s COVID-19 Vaccine Candidate
German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant…
Pharma Faces / Teresa Rodó, Head of Global Healthcare Operations, Merck
PharmaBoardroom recently sat down with Merck’s EVP and Head of Global Healthcare Operations, Teresa Rodó to…
Merck KGaA / Big-Ticket Investments in Manufacturing Scale & Digital Innovation
Merck KGaA has moved to continuously expand its manufacturing capacity and capability in recent years with a number…
Europe / A New Approach to Health Crises in France & Germany
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
News Roundup / German Pharma: February 2020
Some of the top recent stories from Germany, Europe’s leading pharma market according to CPhI, including big…
Bayer: Betting Big on Cell & Gene Therapy
Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as…
Merck Announces EUR 1 Billion HQ Investment
German giant Merck KGaA has announced a EUR one billion investment into its headquarters in Darmstadt, Germany up…
Interview with Elmar Schnee , President of Merck Serono and Member of the…
As a majority family owned group, Merck is also the oldest pharmaceutical company in the world and known throughout…
Interview with Andreas Fibig, CEO, Bayer Schering Pharma
The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth…
Interview with Ralf Göddertz, General Manager of Germany, Austria and…
DAIICHI SANKYO in Germany, Austria and Switzerland DAIICHI SANKYO wants to be a Global Pharma Innovator with…
